LIGNÉE DE CELLULES DENDRITIQUES PLASMACYTOÏDES UTILISÉE EN THÉRAPIE CELLULAIRE ACTIVE OU ADOPTIVE
    7.
    发明公开
    LIGNÉE DE CELLULES DENDRITIQUES PLASMACYTOÏDES UTILISÉE EN THÉRAPIE CELLULAIRE ACTIVE OU ADOPTIVE 有权
    ER IE IE IE IE IE IE IE IE IE IE IE IE IE IE IE IE IE IE IE IE IE IE

    公开(公告)号:EP2276832A1

    公开(公告)日:2011-01-26

    申请号:EP09745821.0

    申请日:2009-05-15

    IPC分类号: C12N5/06 A61K35/12

    摘要: The present invention relates to a method for inducing and amplifying specific effectors, which comprises obtaining pulsed plasmacytoid dendritic cells (pDC) by incubation of a pDC line with at least one antigen, the pulsed pDC being subsequently irradiated and brought into contact with peripheral blood mononuclear cells (PBMC), and cultured or injected into an organism. The pulsed and irradiated pDC and the PBMC share at least one major histocompatibility complex (MHC) allele.

    摘要翻译: 本发明涉及一种用于诱导和扩增特异性效应子的方法,其包括通过将pDC系与至少一种抗原孵育获得脉冲浆细胞样树突状细胞(pDC),脉冲式pDC随后被照射并与外周血单核细胞接触 细胞(PBMC),并培养或注射到生物体中。 脉冲和照射的pDC和PBMC共享至少一种主要的组织相容性复合体(MHC)等位基因。